A Joint Working Group discussed a future strategy for Indo-US Vaccine Action Programme (VAP) recently in New Delhi. Besides discussions on progress of various initiatives being implemented under VAP, the group has considered to add new vaccine development programmes, which include for development of affordable vaccines for dengue, respiratory syncytial virus, malaria etc.
The Department of the Biotechnology has also initiated the partnership proposal for research on human infectious diseases with an international body called Infect-ERA NET. This body comprises research organisations from Europe and Israel. Infect-ERA NET aims to fund joint transnational and translational research by bringing together basic and technology driven applied research approaches for addressing human infections.
